CPH 0.00% 0.9¢ creso pharma limited

Ann: Halucenex prepares North American market entry, page-23

  1. 120 Posts.
    lightbulb Created with Sketch. 10
    This company cannot survive with current management for another 6 months. IMO, it can only survive if another company takes it over with a new management team that knows what they are doing. Wouldn't pay more than 10M though for their current facilities, patents and trademarks.
 
watchlist Created with Sketch. Add CPH (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.